Full funding of VMX-C001 Phase 3 trial, late-stage product development, manufacturing and pre-launch activities VarmX shareholders to receive initial $117m upfront and further potential milestone ...
Management reiterated expectations for FDA approval of LNZ100 by August 2025, with a commercial launch in Q4 2025. Manufacturing activities are aligned to support this timeline, with bulk production ...
Historically start-ups were terrified of anyone outside their immediate organization learning the secrets of their innovations for fear they’d be copied. Those days are gone. Start-ups and even some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback